B

BioInvent International AB
STO:BINV

Watchlist Manager
BioInvent International AB
STO:BINV
Watchlist
Price: 50.4 SEK 0.9% Market Closed
Market Cap: 3.3B SEK
Have any thoughts about
BioInvent International AB?
Write Note

BioInvent International AB
Operating Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

BioInvent International AB
Operating Income Peer Comparison

Comparables:
BIOG B
BONEX
VITR
SOBI
BIOA B

Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
B
BioInvent International AB
STO:BINV
Operating Income
-kr456.1m
CAGR 3-Years
-39%
CAGR 5-Years
-29%
CAGR 10-Years
-53%
Biogaia AB
STO:BIOG B
Operating Income
kr441.3m
CAGR 3-Years
25%
CAGR 5-Years
10%
CAGR 10-Years
N/A
Bonesupport Holding AB
STO:BONEX
Operating Income
kr94.3m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Vitrolife AB
STO:VITR
Operating Income
-kr3.6B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Swedish Orphan Biovitrum AB (publ)
STO:SOBI
Operating Income
kr5.9B
CAGR 3-Years
11%
CAGR 5-Years
11%
CAGR 10-Years
N/A
BioArctic AB
STO:BIOA B
Operating Income
kr264.6m
CAGR 3-Years
N/A
CAGR 5-Years
-11%
CAGR 10-Years
N/A

See Also

What is BioInvent International AB's Operating Income?
Operating Income
-456.1m SEK

Based on the financial report for Sep 30, 2024, BioInvent International AB's Operating Income amounts to -456.1m SEK.

What is BioInvent International AB's Operating Income growth rate?
Operating Income CAGR 10Y
-53%

Over the last year, the Operating Income growth was -35%. The average annual Operating Income growth rates for BioInvent International AB have been -39% over the past three years , -29% over the past five years , and -53% over the past ten years .

Back to Top